Zhejiang Guoguang Biopharmaceutical

Zhejiang Guoguang Biopharmaceutical Co., Ltd. is a Chinese pharmaceutical company headquartered in Jiaxing, Zhejiang Province, specializing in the development and manufacture of chemical and biochemical drugs. As a key subsidiary of the Guoguang Group, the company produces a diverse portfolio that includes metabolic treatments, contrast agents, and immune-modulating therapies. Notable products include Metformin for type 2 diabetes, Iopromide for diagnostic imaging, and Thymosin for immune system support. The company operates advanced, GMP-certified manufacturing facilities and is recognized as a provincial high-tech enterprise. Zhejiang Guoguang Biopharmaceutical is also active in expanding its product line, with recent regulatory filings for new formulations such as Ibuprofen oral suspensions. Its business model encompasses the production of both active pharmaceutical ingredients (APIs) and finished dosage forms for domestic and international markets.